Evoke Pharma (NASDAQ:EVOK) Now Covered by Analysts at StockNews.com
Stock analysts at StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Evoke Pharma Price Performance NASDAQ:EVOK opened at $2.25 on Friday. Evoke Pharma has a one year […]
